Ravi Mysore Shanker

This inventor holds 46 USPTO granted patents and 3 published patent applications, plus 1 CIPO patent and 9 EPO patents, primarily in Pharmaceutical Compositions. Top assignees: Bend Research, Inc., Pfizer Corporation, Durect Corporation. Active years: 2000-2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ravi Mysore Shanker. Retrieved from https://idiyas.com/inventor/ravi-mysore-shanker

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 46 (Patent Applications = 3)

% Patents Active = 41.3

CIPO Patents = 1 (Patent Applications = 4)

EPO Patents = 9 (Patent Applications = 7)

Average Co-Inventor Count = 5.3

ph-index = 9

Forward Citations = 295(Granted Patents)

Location History:

Groton, CT (US) (2000 - 2019)
Stonington, CT (US) (2014 - 2021)

Company Filing History:

Osi Pharmaceuticals, Inc.

patents

5. 1 out of 834,453

Other

patents

Years Active: 2000-2021

Loading Chart...

Areas of Expertise:

Pharmaceutical Compositions

Amorphous Dispersions

Dissolution Variability

Drug Solubility

Low-Solubility Drugs

Rheological Modifiers

Solid Dosage Forms

Cholesteryl Ester Transfer Protein

HMG-CoA Reductase

Polymers

Enhanced Drug Concentrations

Adsorbates

46 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11065250 - Solid dosage forms of palbociclib (2021-07-20),

2. 10357455 - Pharmaceutical compositions of amorphous dispersions of drugs and lipophilic microphase-forming materials (2019-07-23),

3. 10300142 - Compositions with a rheological modifier to reduce dissolution variability (2019-05-28),

4. RE47033 - Pharmaceutical compositions of adsorbates of amorphous drugs and lipophilic microphase-forming materials (2018-09-10),

5. 9932307 - Process for annealing amorphous atorvastatin (2018-04-03),

6. 9907851 - Compositions with a rheological modifier to reduce dissolution variability (2018-03-06),

7. 9855333 - Compositions with a rheological modifier to reduce dissolution variability (2018-01-02),

8. 9572885 - Compositions with a rheological modifier to reduce dissolution variability (2017-02-21),

9. 9555113 - Compositions with a rheological modifier to reduce dissolution variability (2017-01-31),

10. 9486410 - Pharmaceutical compositions of amorphous dispersions of drugs and lipophilic microphase-forming materials (2016-11-08),

11. 9468604 - Pharmaceutical compositions of dispersions of drug and neutral polymers (2016-10-18),

12. 9457095 - Pharmaceutical compositions providing enhanced drug concentrations (2016-10-04),

13. 9445998 - Pharmaceutical dosage forms comprising a low-solubility drug and a polymer (2016-09-20),

14. 9428455 - Process for annealing amorphous atorvastatin (2016-08-30),

15. 9034913 - Process for annealing amorphous atorvastatin (2015-05-19),

Title: Ravi Mysore Shanker: Pioneering Innovations in Pharmaceutical Technology

Introduction:

Ravi Mysore Shanker has cemented his position as a leading figure in the world of inventors through his unwavering passion for innovation and relentless commitment to pushing the boundaries of technology. Hailing from Groton, CT (US), he has dedicated his career to shaping the future of technological advancements.

Latest Patents:

With an impressive portfolio of 46 patents, Ravi Mysore Shanker's recent innovations include groundbreaking inventions such as solid dosage forms of palbociclib, which exhibit desirable pharmacokinetic characteristics. Additionally, his pharmaceutical compositions of amorphous dispersions of drugs and lipophilic microphase-forming materials have paved the way for enhanced drug delivery mechanisms.

Career Highlights:

Having worked with prestigious companies such as Bend Research, Inc. and Pfizer Corporation, Ravi Mysore Shanker has garnered extensive experience in the field of pharmaceutical technology. His innovative solutions have not only revolutionized the industry but have also earned him recognition as a trailblazer in his field.

Collaborations:

Throughout his career, Ravi Mysore Shanker has collaborated with esteemed professionals such as Dwayne Thomas Friesen and Walter Christian Babcock. These collaborations have not only enriched his work but have also led to the development of groundbreaking innovations that have reshaped the landscape of pharmaceutical technology.

Conclusion:

In conclusion, Ravi Mysore Shanker's unparalleled dedication to innovation and his remarkable contributions to the field of pharmaceutical technology have positioned him as a visionary inventor. His relentless pursuit of excellence continues to inspire and shape the future of technological advancements, making him a prominent figure in the world of inventors.

Profile summary based on public USPTO records.